The “Three-Parent Baby”: A Case Study of How Language Frames the Ethical Debate Regarding an Emerging Technology

American Journal of Bioethics

Volumn 15, Issue 12, 2015, Pages 57-60

  Ravitsky, Vardit ^a   Birko, Stanislav ^a   Dupras Leduc, Raphaelle ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; INFANT; LANGUAGE; MORALITY; PARENT;

HUMANS; INFANT; LANGUAGE; MORALS; PARENTS;

EID: 84948977689     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265161.2015.1103809     Document Type: Note

References (19)

1. B.Alexander, 2012. New technique replaces diseased DNA, but would give kids two mothers. NBC News. Available at: http://vitals.nbcnews.com/_news/2012/10/24/14671383-new-technique-replaces-diseased-dna-but-would-give-kids-two-mothers (accessed September28, 2015)
2. P.Amato,, M.Tachibana, M.Sparman, and S.Mitalipov. 2014. Three-parent in vitro fertilization: Gene replacement for the prevention of inherited mitochondrial diseases. Fertility and Sterility 101(1): 31–35. doi:10.1016/j.fertnstert.2013.11.030.
3. D.Beeson,, M.Darnovsky, and A.Lippman. 2015. What's in a name? Variations in terminology of third-party reproduction. Reproductive BioMedicine Online. doi:10.1016/j.rbmo.2015.09.004.
4. I.G.Cohen,, J.Savulescu, and E.Y.Adashi. 2015. Transatlantic lessons in regulation of mitochondrial replacement therapy. Science 348(6231): 178–80. doi:10.1126/science.aaa8153.
5. M.Darnovsky, 2013. A slippery slope to human germline modification. Nature 499:127.
6. M.Darnovsky, 2014. Genetically modified babies. New York Times, February 24. Available at: http://www.nytimes.com/2014/02/24/opinion/genetically-modified-babies.html?_r=1 (accessed September28, 2015).
7. C.Dyer, 2015. UK is set to allow mitochondrial donation after MPs vote in favour. British Medical Journal 350:h657. doi:10.1136/bmj.h657.
8. M.D.Garasic,, and D.Sperling. 2015. Mitochondrial replacement therapy and parenthood. Global Bioethics. doi:10.1080/11287462.2015.1066082.
9. Human Fertilisation and Embryology Authority. 2014. Third scientific review of the safety and efficacy of methods to avoid mitochondrial disease through assisted conception: 2014 Update. Available at: http://www.hfea.gov.uk/docs/Third_Mitochondrial_replacement_scientific_review.pdf (accessed Sep.28, 2015)
10. H.-S.Liu,, and P.-L.Chu. 2014. Three-parent embryo: The therapeutic future for inherited mitochondrial diseases. Journal of the Formosan Medical Association/Taiwan yi zhi. doi:10.1016/j.jfma.2014.04.007.
11. J.D.Loike, 2014. Loaded words. The Scientist. Available at: http://www.the-scientist.com/?articles.view/articleNo/41502/title/Loaded-Words (accessed September28, 2015)
12. S.A.M.McLean, 2015. Mitochondrial DNA transfer. Some reflections from the United Kingdom. BioLaw Journal 2:81–88.
13. S.Mitalipov,, and D.P.Wolf. 2014. Clinical and ethical implications of mitochondrial gene transfer. Trends in Endocrinology & Metabolism 25(1): 5–7. doi:10.1016/j.tem.2013.09.001.
14. S.A.Newman, 2014. Deceptive labeling of a radical embryo construction technique. Huffington Post. Available at: http://www.huffingtonpost.com/stuart-a-newman/deceptive-labeling-of-a-r_b_6213320.html (accessed September28, 2015)
15. Nuffield Council on Bioethics. 2012. Novel techniques for the prevention of mitochondrial DNA disorders: An ethical review. London, UK: Nuffield Council on Bioethics.
16. M.O'Keefe,, S.Perrault, J.Halpern, L.Ikemoto, M.Yarborough, UC North Bioethics Collaboratory for Life & Health Sciences. 2015. “Editing” genes: A case study about how language matters in bioethics. American Journal of Bioethics 15(12): 3–10.
17. A.Pande, 2014. The power of narratives: Negotiating commercial surrogacy in India. In Globalization and transnational surrogacy in India: Outsourcing life, ed. S.Das Gupta, 87–105. New York, NY: Lexington Books.
18. G.R.Passi, 2015. The three parent embryo. Indian Pediatrics 52:261.
19. D.P.Wolf,, N.Mitalipov, and S.Mitalipov. 2015. Mitochondrial replacement therapy in reproductive medicine. Trends in Molecular Medicine 21(2): 68–76. doi:10.1016/j.molmed.2014.12.001.